NO943760L - Hydrazidderivater av 3,4-dihydro-2H-1-benzopyraner - Google Patents

Hydrazidderivater av 3,4-dihydro-2H-1-benzopyraner

Info

Publication number
NO943760L
NO943760L NO943760A NO943760A NO943760L NO 943760 L NO943760 L NO 943760L NO 943760 A NO943760 A NO 943760A NO 943760 A NO943760 A NO 943760A NO 943760 L NO943760 L NO 943760L
Authority
NO
Norway
Prior art keywords
alkyl
benzopyrans
dihydro
free radical
radical scavengers
Prior art date
Application number
NO943760A
Other languages
English (en)
Norwegian (no)
Other versions
NO943760D0 (no
Inventor
J Martin Grisar
Margaret A Petty
Frank Bolkenius
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO943760D0 publication Critical patent/NO943760D0/no
Publication of NO943760L publication Critical patent/NO943760L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
NO943760A 1992-04-07 1994-10-06 Hydrazidderivater av 3,4-dihydro-2H-1-benzopyraner NO943760L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92400972 1992-04-07
PCT/US1993/002311 WO1993020059A1 (en) 1992-04-07 1993-03-12 Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans

Publications (2)

Publication Number Publication Date
NO943760D0 NO943760D0 (no) 1994-10-06
NO943760L true NO943760L (no) 1994-12-06

Family

ID=8211648

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943760A NO943760L (no) 1992-04-07 1994-10-06 Hydrazidderivater av 3,4-dihydro-2H-1-benzopyraner

Country Status (19)

Country Link
EP (1) EP0635011B1 (index.php)
JP (1) JP3226174B2 (index.php)
KR (1) KR950700680A (index.php)
AT (1) ATE146466T1 (index.php)
AU (1) AU675784B2 (index.php)
CA (1) CA2132831C (index.php)
DE (1) DE69306770T2 (index.php)
DK (1) DK0635011T3 (index.php)
ES (1) ES2098730T3 (index.php)
FI (1) FI944678A7 (index.php)
GR (1) GR3022122T3 (index.php)
HU (1) HU215912B (index.php)
IL (1) IL105319A (index.php)
MX (1) MX9301979A (index.php)
NO (1) NO943760L (index.php)
NZ (1) NZ251174A (index.php)
TW (1) TW278076B (index.php)
WO (1) WO1993020059A1 (index.php)
ZA (1) ZA932414B (index.php)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510373A (en) * 1992-04-06 1996-04-23 Merrell Pharmaceuticals Inc. Cardioprotective agents
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5451603A (en) * 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5416098A (en) * 1993-12-30 1995-05-16 Zymogenetics, Inc. Method for treating dermatitis and related conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010505A1 (de) * 1980-03-19 1981-10-01 Basf Ag, 6700 Ludwigshafen Chromanderivate, verfahren zu ihrer herstellung, ihre verwendung als stabilisatoren von organischen materialien sowie diese stabilisatoren enthaltende organische materialien
CA1338012C (en) * 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
EP0369083A1 (en) * 1988-11-14 1990-05-23 Merrell Dow Pharmaceuticals Inc. Cardioprotective tocopherol analogs
EP0412939A3 (en) * 1989-08-11 1991-09-04 Ciba-Geigy Ag Certain benzopyran and benzothiopyran derivatives
DE4000397A1 (de) * 1990-01-09 1991-07-11 Hoechst Ag Lipidselektive antioxidantien sowie deren herstellung und verwendung
KR900016822A (ko) * 1990-04-20 1990-11-14 하라 레이노스께 슬라이드 프로젝터

Also Published As

Publication number Publication date
EP0635011B1 (en) 1996-12-18
FI944678A0 (fi) 1994-10-06
WO1993020059A1 (en) 1993-10-14
CA2132831A1 (en) 1993-10-14
DE69306770D1 (de) 1997-01-30
JPH07505625A (ja) 1995-06-22
HU215912B (hu) 1999-03-29
DE69306770T2 (de) 1997-06-12
NZ251174A (en) 1996-01-26
TW278076B (index.php) 1996-06-11
MX9301979A (es) 1993-11-01
ZA932414B (en) 1993-10-22
GR3022122T3 (en) 1997-03-31
IL105319A (en) 1998-02-22
ES2098730T3 (es) 1997-05-01
AU675784B2 (en) 1997-02-20
HUT68833A (en) 1995-08-28
HU9402882D0 (en) 1995-01-30
DK0635011T3 (da) 1997-01-06
EP0635011A1 (en) 1995-01-25
FI944678L (fi) 1994-10-06
FI944678A7 (fi) 1994-10-06
ATE146466T1 (de) 1997-01-15
JP3226174B2 (ja) 2001-11-05
AU3807293A (en) 1993-11-08
NO943760D0 (no) 1994-10-06
KR950700680A (ko) 1995-02-20
IL105319A0 (en) 1993-08-18
CA2132831C (en) 1998-06-16

Similar Documents

Publication Publication Date Title
NO972811L (no) Benzamidoksimderivat, fremgangsmåte for fremstilling derav, og agrohortikulturbaktericid
NO952854L (no) 1-arylpyrimidin-derivater
GB9211172D0 (en) Compounds
NO975901L (no) Vinyl-pyrrolidinon cefalosporiner med basiske substituenter
DK0508740T3 (da) Thiazolidindionderivater, deres fremstilling og anvendelse.
NO930499L (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og deres anvendelse
NO971555L (no) N-(orto-substituerte benzyloksy)iminderivater og deres anvendelse som fungicider, akaricider eller insekticider
DK26289A (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
NO943760L (no) Hydrazidderivater av 3,4-dihydro-2H-1-benzopyraner
NO933435L (no) Piperidinderivater, deres fremstilling og anvendelse
NO922531L (no) Middel for forhindring av og behandling av fiskesykdommer
NO972256L (no) O-Benzyloksimeterderivater og deres anvendelse som pesticider
DE69518706D1 (de) Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom
ES8203836A1 (es) Procedimiento para la preparacion de nuevas fenilureas
US4670555A (en) Substituted oxadiazinones
NO921723L (no) Nye kinolinforbindelser, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse
PL266099A1 (en) A microbes killing agent and a method of new morpholyne derivatives production
NO952194L (no) Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer
US4782066A (en) Substituted oxadiazinone miticidal compositions and use
NO974810L (no) 3-fenyl-1,4-dialkyl-1,2,4-triazoliumsalter og deres anvendelse som antidepressive midler
DK0427484T3 (da) Hidtil ukendte benzoxazolonforbindelser og deres anvendelse som mikrobicider
NO954764L (no) Psoralen-derivater, deres fremstilling og anvendelse
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE131057T1 (de) 8-chloro-benzothiazepin-verbindung zur prophylaxe und behandlung der folgen der zerebralen nekrose von neurozyten.
MY136018A (en) Di - or trifluoromethanesulfonyl anilide derivative, process for production thereof, and herbicide containing said derivative as active ingredient